AstraZeneca vaccine: Blood clots are "extremely rare" and benefits outweigh risks, regulators conclude. Mahase E. BMJ 2021;373:n931.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mahase E. AstraZeneca vaccine: Blood clots are "extremely rare" and benefits outweigh risks, regulators conclude. BMJ 2021;373:n931.
PMID: 33832929